Details

• Title:

  Pre-clinical Investigation of anti-TFPI-mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding Disorders

• Type:

• Donor:

  Pfizer

• Status:

  Accepting Bids

• Deadline:

  01 Jul 2026

• Duration:

  Maximum 1 year

• Value:

  Up to $50,000 USD per project and up to $50,000 USD for study drug); total available budget $300,000 USD

• Locations:

  Saudi Arabia, Turkey

• Sectors:

  Health

• Sub sectors:

  Health research , Prevention of non-communicable diseases

• Type of Services:

  Research and assessment

• Sub Services:

  Scientific research

• Attachments:

• Post Date

  14 May 2026

• Contact information